Clinical applications of the camptothecins
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1400 (1-3) , 107-119
- https://doi.org/10.1016/s0167-4781(98)00130-4
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Efficacy of camptothecin in progressive multifocal leucoencephalopathyThe Lancet, 1997
- Radiation lethality enhancement with 9-aminocamptothecin: Comparison to other topoisomerase I inhibitorsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiationInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), a novel topoisomerase I and II inhibitor, in cancer patientsAnti-Cancer Drugs, 1996
- Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.Proceedings of the National Academy of Sciences, 1995
- Mutagenicity and carcinogenicity of topoisomerase-interactive agentsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- Phase I and pharmacokinetic trial of weekly CPT-11.Journal of Clinical Oncology, 1993
- A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some AnaloguesJournal of Pharmaceutical Sciences, 1992
- Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase IInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityJournal of Medicinal Chemistry, 1989